ProKidney Capital Stock from 2010 to 2025

PROK Stock

USD 0.94 0.05 4.85%

ProKidney Corp Capital Stock yearly trend continues to be quite stable with very little volatility. The value of Capital Stock is projected to decrease to about 27.6 K. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

29 K

Current Value

27.6 K

Quarterly Volatility

57.5 M

Credit Downgrade

Yuan Drop

Covid

Check ProKidney Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ProKidney Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 8.6 K or Selling General Administrative of 34.8 M, as well as many indicators such as Price To Sales Ratio of 2.2 K, Dividend Yield of 0.0 or Days Sales Outstanding of 9.4 K. ProKidney financial statements analysis is a perfect complement when working with ProKidney Corp Valuation or Volatility modules.

Check out the analysis of ProKidney Corp Correlation against competitors.

For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

Latest ProKidney Corp's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of ProKidney Corp over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. ProKidney Corp's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ProKidney Corp's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

ProKidney Capital Stock Regression Statistics

	Arithmetic Mean	91,689,909
	Geometric Mean	14,617,606
	Coefficient Of Variation	62.71
	Mean Deviation	45,832,011
	Median	116,228,000
	Standard Deviation	57,498,135
	Sample Variance	3306T
	Range	188.4M
	R-Value	(0.62)
	Mean Square Error	2190.9T
	R-Squared	0.38
	Significance	0.01
	Slope	(7,459,253)
	Total Sum of Squares	49590.5T

ProKidney Capital Stock History

	2025	27.6 K
	2024	29 K
	2023	23 K
	2022	24 K
	2021	188.4 M

Other Fundumenentals of ProKidney Corp

Issuance Of Capital Stock

ProKidney Corp Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Good Will	Net Invested Capital	Capital Stock	Net Working Capital	Short Term Debt	Capital Surpluse	Current Deferred Revenue	Net Receivables
Total Assets		-0.98	0.94	-0.75	-0.96	0.87	0.76	1.0	-0.61	-0.85	0.71	-0.85	-0.97	-0.91	1.0	0.89	-0.42	0.54	0.53
Total Stockholder Equity	-0.98		-0.98	0.67	0.99	-0.88	-0.85	-0.97	0.62	0.9	-0.7	0.86	1.0	0.95	-0.98	-0.9	0.56	-0.58	-0.59
Net Tangible Assets	0.94	-0.98		-0.61	-1.0	0.86	0.91	0.93	-0.62	-0.89	0.71	-0.87	-0.99	-0.94	0.95	0.89	-0.69	0.69	0.71
Net Debt	-0.75	0.67	-0.61		0.63	-0.46	-0.28	-0.78	0.39	0.58	-0.44	0.55	0.66	0.61	-0.79	-0.38	0.13	-0.13	-0.13
Retained Earnings	-0.96	0.99	-1.0	0.63		-0.89	-0.9	-0.95	0.65	0.88	-0.74	0.89	1.0	0.94	-0.96	-0.91	0.63	-0.65	-0.66
Accounts Payable	0.87	-0.88	0.86	-0.46	-0.89		0.84	0.85	-0.77	-0.62	0.85	-0.94	-0.88	-0.71	0.85	0.89	-0.41	0.47	0.48
Total Liab	0.76	-0.85	0.91	-0.28	-0.9	0.84		0.74	-0.67	-0.71	0.75	-0.86	-0.86	-0.78	0.76	0.87	-0.82	0.81	0.84
Total Current Assets	1.0	-0.97	0.93	-0.78	-0.95	0.85	0.74		-0.6	-0.85	0.69	-0.84	-0.96	-0.91	1.0	0.87	-0.41	0.52	0.51
Intangible Assets	-0.61	0.62	-0.62	0.39	0.65	-0.77	-0.67	-0.6		0.27	-0.98	0.8	0.62	0.43	-0.61	-0.59	0.38	-0.4	-0.41
Common Stock	-0.85	0.9	-0.89	0.58	0.88	-0.62	-0.71	-0.85	0.27		-0.36	0.56	0.9	0.99	-0.86	-0.79	0.55	-0.56	-0.58
Property Plant Equipment	0.71	-0.7	0.71	-0.44	-0.74	0.85	0.75	0.69	-0.98	-0.36		-0.89	-0.7	-0.51	0.7	0.7	-0.43	0.5	0.5
Good Will	-0.85	0.86	-0.87	0.55	0.89	-0.94	-0.86	-0.84	0.8	0.56	-0.89		0.86	0.67	-0.85	-0.83	0.55	-0.6	-0.61
Net Invested Capital	-0.97	1.0	-0.99	0.66	1.0	-0.88	-0.86	-0.96	0.62	0.9	-0.7	0.86		0.95	-0.97	-0.89	0.59	-0.59	-0.6
Capital Stock	-0.91	0.95	-0.94	0.61	0.94	-0.71	-0.78	-0.91	0.43	0.99	-0.51	0.67	0.95		-0.91	-0.84	0.59	-0.59	-0.61
Net Working Capital	1.0	-0.98	0.95	-0.79	-0.96	0.85	0.76	1.0	-0.61	-0.86	0.7	-0.85	-0.97	-0.91		0.85	-0.45	0.52	0.52
Short Term Debt	0.89	-0.9	0.89	-0.38	-0.91	0.89	0.87	0.87	-0.59	-0.79	0.7	-0.83	-0.89	-0.84	0.85		-0.48	0.72	0.7
Capital Surpluse	-0.42	0.56	-0.69	0.13	0.63	-0.41	-0.82	-0.41	0.38	0.55	-0.43	0.55	0.59	0.59	-0.45	-0.48		-0.8	-0.86
Current Deferred Revenue	0.54	-0.58	0.69	-0.13	-0.65	0.47	0.81	0.52	-0.4	-0.56	0.5	-0.6	-0.59	-0.59	0.52	0.72	-0.8		1.0
Net Receivables	0.53	-0.59	0.71	-0.13	-0.66	0.48	0.84	0.51	-0.41	-0.58	0.5	-0.61	-0.6	-0.61	0.52	0.7	-0.86	1.0

Click cells to compare fundamentals

About ProKidney Corp Financial Statements

ProKidney Corp investors utilize fundamental indicators, such as Capital Stock, to predict how ProKidney Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Capital Stock	29 K	27.6 K
Issuance Of Capital Stock	144.3 M	151.5 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether ProKidney Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ProKidney Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Prokidney Corp Stock. Highlighted below are key reports to facilitate an investment decision about Prokidney Corp Stock:

How To Invest In ProKidney

Details

Is ProKidney Stock a good investment?

Details

What is ProKidney Corp's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of ProKidney Corp Correlation against competitors.

For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.62)

Revenue Per Share

0.001

Return On Assets

(0.26)

Return On Equity

(0.41)

The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ProKidney Capital Stock from 2010 to 2025

Latest ProKidney Corp's Capital Stock Growth Pattern

ProKidney Capital Stock Regression Statistics

ProKidney Capital Stock History

Other Fundumenentals of ProKidney Corp

ProKidney Corp Capital Stock component correlations

About ProKidney Corp Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY